{"id":15291,"date":"2026-02-13T16:16:49","date_gmt":"2026-02-13T15:16:49","guid":{"rendered":"https:\/\/www.cbd.fr\/blog\/?p=15291"},"modified":"2026-02-13T16:16:51","modified_gmt":"2026-02-13T15:16:51","slug":"hhc-hhco-hhcp-why-these-molecules-are-banned-in-france","status":"publish","type":"post","link":"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/","title":{"rendered":"HHC, HHCO, HHCP: why these molecules are banned in France"},"content":{"rendered":"<p>The emergence of <strong>new cannabis derivatives<\/strong> such as <a href=\"https:\/\/www.cbd.fr\/hhc\" data-internallinksmanager029f6b8e52c=\"16\" title=\"HHC\">HHC<\/a>, HHCO, and HHCP has sent shockwaves through the cannabinoid world. Their <strong>growing popularity<\/strong> among consumers seeking legal alternatives to <a href=\"https:\/\/www.cbd.fr\/198thccbd\" data-internallinksmanager029f6b8e52c=\"17\" title=\"thc - t\u00e9trahydrocannabinol\">THC<\/a> quickly attracted the attention of French health authorities. Faced with the increasing use of these products, their <strong>sale and consumption were banned<\/strong> in France, raising numerous questions about their <strong>psychoactive effects<\/strong>, their regulatory status, and the associated risks. This article explains the reasons and the legal framework that justify this ban.<\/p>\n\n<h2><\/h2>\n<p><strong>What are HHC, HHCO, and HHCP?<\/strong> HHC, HHCO, and HHCP <strong>all belong to the<\/strong>cannabinoid <strong>family. Unlike natural compounds such as CBD or THC, they are distinguished by their chemical structure and method of extraction. Although they are considered cannabis derivatives, their origin raises questions about their safety.<\/strong> <strong>HHC (hexahydrocannabinol), HHCO (hexahydrocannabinol acetate), and HHCP (hexahydrocannabiphorol) are designed to mimic some of the effects of THC. However, they are most often synthetic molecules resulting from chemical transformations of natural hemp extracts. This fundamental distinction already raises serious concerns regarding regulation and public health.<\/strong><\/p>\n<p>Psychoactive Effects and Associated Risks: One of the main reasons for the ban on these substances in France is their similarity to THC, the main psychoactive compound in cannabis. HHC, HHCO, and HHCP induce altered states of consciousness, sometimes more intense or unpredictable, due to their potency or method of manufacture. <strong><\/strong>The similarity to THC is not limited to the euphoria sought by some users. Several reports indicate <strong>Side effects<\/strong> such as <strong>tremors<\/strong> , <strong>vomiting<\/strong>, episodes of <strong>acute anxiety<\/strong>, <strong>bad trips<\/strong> , or even <strong>mental confusion<\/strong>. These worrying manifestations directly contribute to the<\/p>\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_80 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Sommaire<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #43b981;color:#43b981\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #43b981;color:#43b981\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/#risk_of_abuse_and_addiction\" >risk of abuse and addiction<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/#results_from_analyses_conducted_by_bodies_such_as_the\" >results from analyses conducted by bodies such as the<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/#_once_flourishing_thanks_to_legal_loopholes_and_the_speed_of_e-commerce_now_become_subject_to\" >, once flourishing thanks to legal loopholes and the speed of e-commerce, now become subject to<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/#for_users_and_sellers\" >for users and sellers<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/#HHCP\" >HHCP<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/#Prohibited\" >Prohibited<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"risk_of_abuse_and_addiction\"><\/span>risk of abuse and addiction<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>, which is of particular alarm to health authorities. To gain a deeper understanding of current regulations, a detailed look at the<strong>ban on THCP by the ANSM (French National Agency for Medicines and Health Products Safety)<\/strong> helps to better understand the measures recently taken against these synthetic cannabinoids. <strong>Limited safety data<\/strong>It remains difficult to accurately assess the extent of the danger when few rigorous studies analyze the <strong>medium- or long-term toxicity<\/strong> of these molecules. Unlike <strong>natural THC<\/strong> which has been studied for a long time, these new <strong>cannabis derivatives<\/strong>suffer from a real lack of scientific perspective. This uncertainty leads health agencies to apply the<\/p>\n<p>precautionary principle <strong>to synthetic molecules<\/strong> that are still poorly understood.<strong>The reported incidents concern both<\/strong> physical <strong>and<\/strong>psychological <strong>reactions. Some people report cardiac or neurological problems, increasing the vigilance of French legislators regarding these products.<\/strong><strong>A significant addictive potential<\/strong>These new substances also present a significant addictive potential. <strong><\/strong> Like other potent cannabinoids, <strong>they act on the pleasure and reinforcement pathways, thus increasing the risk of abuse and dependence,<\/strong>particularly among young people or vulnerable populations. <strong>The complete lack of regulation regarding the purity or concentration of these products facilitates the circulation of cut or overdosed substances, further aggravating the health consequences and multiplying risky behaviors.<\/strong>The legal framework in France<a href=\"https:\/\/www.cbd.fr\/blog\/interdiction-du-thcp-tout-ce-que-vous-devez-savoir\/\">The ban in France on HHC, HHCO, and HHCP stems directly from a desire to protect the population from new molecules whose effects remain largely unknown.<\/a> Classification as a narcotic<\/p>\n\n<h3><span class=\"ez-toc-section\" id=\"results_from_analyses_conducted_by_bodies_such_as_the\"><\/span>results from analyses conducted by bodies such as the<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>National Agency for the Safety of Medicines and Health Products (ANSM). <strong><\/strong> Upon their arrival on the market, the authorities chose to <strong>act quickly.<\/strong>  <strong>This strategy aims to<\/strong> limit the spread <strong>of these substances, anticipating both their<\/strong> potential for abuse <strong>and possible circumvention of regulations on<\/strong> traditional cannabis.<\/p>\n<p> <strong>The<\/strong> lack of transparency regarding the production methods <strong>of these cannabinoids has only reinforced the firmness of the French approach. To understand how these bans take effect and are disseminated within the sector, you can consult a dedicated section on the<\/strong>official ban of several chemical cannabinoids. <strong><\/strong> How does the ANSM&#8217;s decision work?<\/p>\n\n<h3><\/h3>\n<p>The <strong>ANSM<\/strong>has the power to provide expertise and make recommendations on all <strong>substances that pose a risk to public health<\/strong>or that could be diverted for recreational purposes. It relies on feedback from healthcare professionals, analyses from toxicological laboratories, and the observation of emerging phenomena. <strong><\/strong>When a<\/p>\n<p>proven or suspected risk<strong>is identified, even without a major incident reported, classification as a narcotic<\/strong> may be decided. This automatically entails the <strong>prohibition of its manufacture, import, sale, and consumption<\/strong> throughout French territory.<\/p>\n\n<h2><\/h2>\n<p>Biological and legal similarity to THC<strong>At the molecular level, these<\/strong> new compounds <strong>present a marked similarity to<\/strong> THC <strong>, sufficient to generate similar<\/strong> psychoactive effects. <strong><\/strong> This similarity facilitates rapid assimilation by the nervous system, justifying the severity of the regulatory framework in place.<strong><\/strong>This criterion implies that any<\/p>\n<p>molecule capable of imitating or exceeding the effects of THC<strong>almost automatically falls into the list of<\/strong>illicit drugs <strong>, thus ensuring harmonization of health controls regarding<\/strong> cannabis-derived products <strong><\/strong> Consequences of the ban on the French market <strong>The application of the<\/strong>French law<strong>leads to immediate changes in the availability of these<\/strong> controversial molecules<a href=\"https:\/\/www.cbd.fr\/blog\/interdiction-du-thcp-tout-ce-que-vous-devez-savoir\/\">.<\/a>Online sales<\/p>\n\n<h3><span class=\"ez-toc-section\" id=\"_once_flourishing_thanks_to_legal_loopholes_and_the_speed_of_e-commerce_now_become_subject_to\"><\/span>, once flourishing thanks to legal loopholes and the speed of e-commerce, now become subject to<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>criminal prosecution<strong>as soon as the official decree is published.<\/strong>  <strong>Specialized retailers<\/strong> must immediately remove all goods containing<\/p>\n<p>HHC, HHCO, or HHCP <strong>under penalty of heavy sanctions. Stocks are destroyed or sealed. For consumers, access to these products disappears abruptly, often without clear information about the<\/strong> risks previously involved. <strong><\/strong> Immediate removal<strong>of the offending items from physical stores and online shops<\/strong> Legal risk<\/p>\n\n<h3><span class=\"ez-toc-section\" id=\"for_users_and_sellers\"><\/span>for users and sellers<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Fluctuation and then cessation of supply <strong>on the black market<\/strong> Substitution phenomenon <strong>towards other molecules or forms of<\/strong>synthetic cannabinoids <strong>Deterrent effect<\/strong>on experimentation with new products<\/p>\n<p>The agility of the <strong>illegal market<\/strong> sometimes makes it difficult to monitor successive bans. Hence the need, regularly reiterated by public authorities, to accompany each new ban with <strong>targeted communication<\/strong>on the dangers associated with these <strong>artificial alternatives<\/strong>.<\/p>\n\n<h2><\/h2>\n<p>Frequently asked questions about HHC, HHCO, HHCP and their status in France <strong>What are the most common side effects related to the consumption of HHC, HHCO or HHCP?<\/strong> Anxiety <strong>and episodes of<\/strong>bad trips <strong>Body tremors<\/strong>Vomiting <strong>and severe nausea<\/strong> Mental confusion<\/p>\n<p>and disorientation <strong>For some people, the consumption of these<\/strong> synthetic molecules <strong>also leads to<\/strong> cardiovascular problems <strong>, palpitations, and paranoid episodes. The<\/strong> side effects<\/p>\n\n<ul>\n  <li><strong>The effects vary depending on the individual, the dose, and the purity of the product used.<\/strong> <\/li>\n  <li><strong>Why does France classify these molecules as narcotics?<\/strong> <\/li>\n  <li><strong>The classification as a narcotic is based on several criteria:<\/strong> Similarity to THC in terms of psychoactive effects<\/li>\n  <li><strong>Lack of reliable studies on long-term safety<\/strong> Reported cases of abuse and dependence <strong>Synthetic molecule that is difficult to control<\/strong><\/li>\n  <li><strong>Such regulations aim to reduce the distribution of substances that pose a potential health risk, while maintaining the strict legal framework surrounding cannabis and its derivatives.<\/strong> Can these cannabinoids still be bought or consumed in France?<\/li>\n<\/ul>\n\n<p> <strong>No, since the ANSM&#8217;s decision, the sale and consumption of HHC, HHCO, and HHCP are prohibited. Any violation is punishable by fines to imprisonment. Shops, including online retailers, are no longer allowed to offer them. Product<\/strong> Status in France <strong>HHC<\/strong> Prohibited <strong>HHCO<\/strong>Prohibited<\/p>\n\n<h2><span class=\"ez-toc-section\" id=\"HHCP\"><\/span>HHCP<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n<div>\n  <div>\n    <h3><span class=\"ez-toc-section\" id=\"Prohibited\"><\/span>Prohibited<span class=\"ez-toc-section-end\"><\/span><\/h3>\n    <div><div>\n      <ul>\n        <li><strong>Obtaining these products, even from foreign sources, remains illegal in France.<\/strong> What are the differences between these molecules and legal CBD? <strong><\/strong><\/li>\n        <li><strong>CBD provides relief without causing significant psychoactive effects, unlike the substances mentioned.<\/strong><\/li>\n        <li><strong>CBD is not classified as a narcotic as long as its THC content remains within the legal limit.<\/strong> CBD has benefited from extensive studies demonstrating its relative safety in adults, whereas HHC, HHCO, and HHCP lack solid scientific literature. Other synthetic cannabis derivatives therefore struggle to offer the same level of confidence to users and health authorities.<\/li>\n        <li><strong><\/strong> <\/li>\n      <\/ul>\n      <p> <strong><\/strong>  <strong><\/strong> <strong><\/strong> <\/p>\n    <\/div><\/div>\n  <\/div>\n  <div>\n    <h3><\/h3>\n    <div><div>\n      <p> <strong><\/strong> <\/p>\n      <ol>\n        <li><strong><\/strong>  <strong><\/strong><\/li>\n        <li><strong><\/strong> <\/li>\n        <li> <strong><\/strong> <\/li>\n        <li><strong><\/strong> <\/li>\n      <\/ol>\n      <p> <strong><\/strong>  <strong><\/strong> <strong><\/strong> <\/p>\n    <\/div><\/div>\n  <\/div>\n  <div>\n    <h3><\/h3>\n    <div><div>\n      <p> <strong><\/strong> <strong><\/strong>  <strong><\/strong> <\/p>\n      <table>\n        <tr><th><\/th><th><\/th><\/tr>\n        <tr><td><\/td><td><strong><\/strong><\/td><\/tr>\n        <tr><td><\/td><td><strong><\/strong><\/td><\/tr>\n        <tr><td><\/td><td><strong><\/strong><\/td><\/tr>\n      <\/table>\n      <p><strong><\/strong> <strong><\/strong> <\/p>\n    <\/div><\/div>\n  <\/div>\n  <div>\n    <h3><\/h3>\n    <div><div>\n      <ul>\n        <li> <strong><\/strong> <strong><\/strong><\/li>\n        <li> <strong><\/strong> <\/li>\n        <li> <strong><\/strong>  <strong><\/strong> <\/li>\n      <\/ul>\n      <p> <strong><\/strong>  <strong><\/strong><\/p>\n    <\/div><\/div>\n  <\/div>\n<\/div>\n\n\n\n<div class=\"kk-star-ratings kksr-auto kksr-align-left kksr-valign-bottom\"\n    data-payload='{&quot;align&quot;:&quot;left&quot;,&quot;id&quot;:&quot;15291&quot;,&quot;slug&quot;:&quot;default&quot;,&quot;valign&quot;:&quot;bottom&quot;,&quot;ignore&quot;:&quot;&quot;,&quot;reference&quot;:&quot;auto&quot;,&quot;class&quot;:&quot;&quot;,&quot;count&quot;:&quot;0&quot;,&quot;legendonly&quot;:&quot;&quot;,&quot;readonly&quot;:&quot;&quot;,&quot;score&quot;:&quot;0&quot;,&quot;starsonly&quot;:&quot;&quot;,&quot;best&quot;:&quot;5&quot;,&quot;gap&quot;:&quot;5&quot;,&quot;greet&quot;:&quot;Notez cet article&quot;,&quot;legend&quot;:&quot;0\\\/5 - (0 vote)&quot;,&quot;size&quot;:&quot;24&quot;,&quot;title&quot;:&quot;HHC, HHCO, HHCP: why these molecules are banned in France&quot;,&quot;width&quot;:&quot;0&quot;,&quot;_legend&quot;:&quot;{score}\\\/{best} - ({count} {votes})&quot;,&quot;font_factor&quot;:&quot;1.25&quot;}'>\n            \n<div class=\"kksr-stars\">\n    \n<div class=\"kksr-stars-inactive\">\n            <div class=\"kksr-star\" data-star=\"1\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n            <div class=\"kksr-star\" data-star=\"2\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n            <div class=\"kksr-star\" data-star=\"3\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n            <div class=\"kksr-star\" data-star=\"4\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n            <div class=\"kksr-star\" data-star=\"5\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n    <\/div>\n    \n<div class=\"kksr-stars-active\" style=\"width: 0px;\">\n            <div class=\"kksr-star\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n            <div class=\"kksr-star\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n            <div class=\"kksr-star\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n            <div class=\"kksr-star\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n            <div class=\"kksr-star\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n    <\/div>\n<\/div>\n                \n\n<div class=\"kksr-legend\" style=\"font-size: 19.2px;\">\n            <span class=\"kksr-muted\">Notez cet article<\/span>\n    <\/div>\n    <\/div>\n","protected":false},"excerpt":{"rendered":"<p>The emergence of new cannabis derivatives such as HHC, HHCO, and HHCP has sent shockwaves through the cannabinoid world. Their growing popularity among consumers seeking legal alternatives to THC quickly attracted the attention of French health authorities. Faced with the increasing use of these products, their sale and consumption were banned in France, raising numerous [&hellip;]<\/p>\n","protected":false},"author":90,"featured_media":13879,"comment_status":"closed","ping_status":"open","sticky":false,"template":"default\n","format":"standard","meta":{"_sitemap_exclude":false,"_sitemap_priority":"","_sitemap_frequency":"","footnotes":""},"categories":[1043],"tags":[],"class_list":["post-15291","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cbd-legislation-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.9 (Yoast SEO v26.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>HHC, HHCO, HHCP: why these molecules are banned in France - CBD Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\ud83c\udf31HHC, HHCO, HHCP: why these molecules are banned in France - CBD.fr \ud83c\udf31\" \/>\n<meta property=\"og:description\" content=\"The emergence of new cannabis derivatives such as HHC, HHCO, and HHCP has sent shockwaves through the cannabinoid world. Their growing popularity among consumers seeking legal alternatives to THC quickly attracted the attention of French health authorities. Faced with the increasing use of these products, their sale and consumption were banned in France, raising numerous [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/\" \/>\n<meta property=\"og:site_name\" content=\"CBD Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cbdfrr\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-13T15:16:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-13T15:16:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cbd.fr\/blog\/wp-content\/uploads\/2025\/08\/hhc_hhco_hhcp_pourquoi_ces_mol_cules_sont_interdites_en_france.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1344\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Julien\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Julien\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"HHC, HHCO, HHCP: why these molecules are banned in France - CBD Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/","og_locale":"fr_FR","og_type":"article","og_title":"\ud83c\udf31HHC, HHCO, HHCP: why these molecules are banned in France - CBD.fr \ud83c\udf31","og_description":"The emergence of new cannabis derivatives such as HHC, HHCO, and HHCP has sent shockwaves through the cannabinoid world. Their growing popularity among consumers seeking legal alternatives to THC quickly attracted the attention of French health authorities. Faced with the increasing use of these products, their sale and consumption were banned in France, raising numerous [&hellip;]","og_url":"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/","og_site_name":"CBD Blog","article_publisher":"https:\/\/www.facebook.com\/cbdfrr\/","article_published_time":"2026-02-13T15:16:49+00:00","article_modified_time":"2026-02-13T15:16:51+00:00","og_image":[{"width":1344,"height":768,"url":"https:\/\/www.cbd.fr\/blog\/wp-content\/uploads\/2025\/08\/hhc_hhco_hhcp_pourquoi_ces_mol_cules_sont_interdites_en_france.webp","type":"image\/webp"}],"author":"Julien","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Julien","Dur\u00e9e de lecture estim\u00e9e":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/#article","isPartOf":{"@id":"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/"},"author":{"name":"Julien","@id":"https:\/\/www.cbd.fr\/blog\/#\/schema\/person\/d78b472d184ec8ae4135d454e3338c04"},"headline":"HHC, HHCO, HHCP: why these molecules are banned in France","datePublished":"2026-02-13T15:16:49+00:00","dateModified":"2026-02-13T15:16:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/"},"wordCount":1240,"publisher":{"@id":"https:\/\/www.cbd.fr\/blog\/#organization"},"image":{"@id":"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cbd.fr\/blog\/wp-content\/uploads\/2025\/08\/hhc_hhco_hhcp_pourquoi_ces_mol_cules_sont_interdites_en_france.webp","articleSection":["CBD legislation"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/","url":"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/","name":"HHC, HHCO, HHCP: why these molecules are banned in France - CBD Blog","isPartOf":{"@id":"https:\/\/www.cbd.fr\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/#primaryimage"},"image":{"@id":"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cbd.fr\/blog\/wp-content\/uploads\/2025\/08\/hhc_hhco_hhcp_pourquoi_ces_mol_cules_sont_interdites_en_france.webp","datePublished":"2026-02-13T15:16:49+00:00","dateModified":"2026-02-13T15:16:51+00:00","breadcrumb":{"@id":"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/#primaryimage","url":"https:\/\/www.cbd.fr\/blog\/wp-content\/uploads\/2025\/08\/hhc_hhco_hhcp_pourquoi_ces_mol_cules_sont_interdites_en_france.webp","contentUrl":"https:\/\/www.cbd.fr\/blog\/wp-content\/uploads\/2025\/08\/hhc_hhco_hhcp_pourquoi_ces_mol_cules_sont_interdites_en_france.webp","width":1344,"height":768,"caption":"HHC HHCO HHCP interdit France"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cbd.fr\/blog\/en\/hhc-hhco-hhcp-why-these-molecules-are-banned-in-france\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"CBD Blog","item":"https:\/\/www.cbd.fr\/blog\/"},{"@type":"ListItem","position":2,"name":"CBD legislation","item":"https:\/\/www.cbd.fr\/blog\/en\/category\/cbd-legislation-en\/"},{"@type":"ListItem","position":3,"name":"HHC, HHCO, HHCP: why these molecules are banned in France"}]},{"@type":"WebSite","@id":"https:\/\/www.cbd.fr\/blog\/#website","url":"https:\/\/www.cbd.fr\/blog\/","name":"CBD Blog","description":"Le meilleur blog de CBD et du chanvre en France par CBD.fr","publisher":{"@id":"https:\/\/www.cbd.fr\/blog\/#organization"},"alternateName":"CBD.fr","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cbd.fr\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.cbd.fr\/blog\/#organization","name":"CBD.fr","alternateName":"CBD.fr","url":"https:\/\/www.cbd.fr\/blog\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cbd.fr\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.cbd.fr\/blog\/wp-content\/uploads\/2023\/01\/logo-cbd.png","contentUrl":"https:\/\/www.cbd.fr\/blog\/wp-content\/uploads\/2023\/01\/logo-cbd.png","width":215,"height":100,"caption":"CBD.fr"},"image":{"@id":"https:\/\/www.cbd.fr\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cbdfrr\/","https:\/\/www.instagram.com\/cbdfr\/","https:\/\/www.youtube.com\/@CBD_fr","https:\/\/www.linkedin.com\/company\/cbd-fr\/"],"description":"CBD.fr est le leaders fran\u00e7ais du bien-\u00eatre et du CBD, proposant une large gamme de produits \u00e0 base de chanvre rigoureusement s\u00e9lectionn\u00e9s. Expertise, qualit\u00e9 et p\u00e9dagogie sont au c\u0153ur de l\u2019exp\u00e9rience CBD.fr.","email":"support@cbd.fr","telephone":"0189720196","legalName":"CBD.fr","foundingDate":"2021-01-01","taxID":"760933","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"11","maxValue":"50"}},{"@type":"Person","@id":"https:\/\/www.cbd.fr\/blog\/#\/schema\/person\/d78b472d184ec8ae4135d454e3338c04","name":"Julien","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cbd.fr\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/58f2f1b1e71c329d0226efe2cc40174640e1757e077dac013c980f3ee43c73a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/58f2f1b1e71c329d0226efe2cc40174640e1757e077dac013c980f3ee43c73a0?s=96&d=mm&r=g","caption":"Julien"},"description":"R\u00e9dacteur en chef sp\u00e9cialis\u00e9 en CBD Julien, n\u00e9 le 17 juillet 1978 en r\u00e9gion Parisienne, est un \u00e9minent r\u00e9dacteur et expert dans le domaine des produits \u00e0 base de CBD. Suite \u00e0 ses \u00e9tudes, Julien a d\u00e9velopp\u00e9 une passion pour les rem\u00e8des naturels, dont le CBD. En 2022, il int\u00e8gre l\u2019\u00e9quipe du site CBD.fr en qualit\u00e9 d\u2019expert et de contributeur r\u00e9gulier. Gr\u00e2ce \u00e0 son expertise scientifique et une \u00e9criture claire, Julien aide \u00e0 d\u00e9mystifier les aspects complexes du CBD, tout en mettant en lumi\u00e8re ses bienfaits et applications potentielles \u00e0 travers ses articles et participations \u00e0 des conf\u00e9rences.","honorificPrefix":"Mr","gender":"male","knowsAbout":["CBD","Cannabis","Copywriter"],"knowsLanguage":["French"],"jobTitle":"Editor-in-chief specializing in CBD","worksFor":"CBD.fr","url":"https:\/\/www.cbd.fr\/blog\/author\/redac-cbd\/"}]}},"_links":{"self":[{"href":"https:\/\/www.cbd.fr\/blog\/wp-json\/wp\/v2\/posts\/15291","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cbd.fr\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cbd.fr\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cbd.fr\/blog\/wp-json\/wp\/v2\/users\/90"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cbd.fr\/blog\/wp-json\/wp\/v2\/comments?post=15291"}],"version-history":[{"count":1,"href":"https:\/\/www.cbd.fr\/blog\/wp-json\/wp\/v2\/posts\/15291\/revisions"}],"predecessor-version":[{"id":15292,"href":"https:\/\/www.cbd.fr\/blog\/wp-json\/wp\/v2\/posts\/15291\/revisions\/15292"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cbd.fr\/blog\/wp-json\/wp\/v2\/media\/13879"}],"wp:attachment":[{"href":"https:\/\/www.cbd.fr\/blog\/wp-json\/wp\/v2\/media?parent=15291"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cbd.fr\/blog\/wp-json\/wp\/v2\/categories?post=15291"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cbd.fr\/blog\/wp-json\/wp\/v2\/tags?post=15291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}